Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines-Reference-Cited by-同舟云学术

Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines

Published:2020-02-21 Issue:5 Volume:28 Page:2485-2498
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Logan Richard M., ,Al-Azri Abdul Rahman,Bossi Paolo,Stringer Andrea M.,Joy Jamie K.,Soga Yoshihiko,Ranna Vinisha,Vaddi Anusha,Raber-Durlacher Judith E.,Lalla Rajesh V.,Cheng Karis Kin Fong,Elad Sharon

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-019-05170-9.pdf

Reference98 articles.

1. Abitbol AA, Sridhar KS, Lewin AA, Schwade JG, Raub W Jr, Wolfson A, Gonzalez-Angulo C, Adessa A, Goodwin WJ, Markoe AM (1997) Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and mitomycin-C (+/- granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma. Cancer 80:266–276

2. Bez C, Demarosi F, Sardella A, Lodi G, Bertolli VG, Annaloro C, Rimondini L, Porter SR, Carrassi A (1999) GM-CSF mouthrinses in the treatment of severe oral mucositis: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88:311–315

3. Bianchi L, Ginebri A, Hagman JH, Francesconi F, Carboni I, Chimenti S (2002) Local treatment of chronic cutaneous leg ulcers with recombinant human granulocyte-macrophage colony-stimulating factor. J Eur Acad Dermatol Venereol 16:595–598

4. Blazar BR, Weisdorf DJ, DeFor T, Goldman A, Braun T, Silver S, Ferrara JL (2006) Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). Blood 108:3216–3222

5. Blijlevens N, de Chateau M, Krivan G, Rabitsch W, Szomor A, Pytlik R, Lissmats A, Johnsen HE, de Witte T, Einsele H, Ruutu T, Niederwieser D (2013) In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burden. Bone marrow transplantation 48:966–971

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prevalence of oral mucositis after radiotherapy in patients with Head and Neck Cancer and its associated factors: a meta-analysis;Clinical and Translational Oncology;2024-09-14

2. Tolerability and Safety of a New Oral Device for Enhancing Prevention and Treatment of Oral Mucositis in a Group of Patients with Hematologic Malignancies Undergoing Chemotherapy;2024-09-04

3. Efficacy of Nebulized GM-CSF Inhalation in Preventing Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Retrospective Study;Heliyon;2024-09

4. Photobiomodulation with light-emitting diode in the management of oral mucositis induced by antineoplastic treatments: a systematic review;Lasers in Dental Science;2024-08-19

5. The effect of probiotics on severe oral mucositis in cancer patients undergoing chemotherapy and/or radiotherapy: A meta-analysis;Journal of Stomatology, Oral and Maxillofacial Surgery;2024-08